Canada markets closed

Vor Biopharma Inc. (VOR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.7700+0.0500 (+2.91%)
At close: 04:00PM EDT
1.7200 -0.05 (-2.82%)
After hours: 07:06PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 117.33M
Enterprise Value 15.82M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.78
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.13

Trading Information

Stock Price History

Beta (5Y Monthly) -0.37
52-Week Change 3-56.35%
S&P500 52-Week Change 323.10%
52 Week High 35.7000
52 Week Low 31.6200
50-Day Moving Average 31.9942
200-Day Moving Average 32.2516

Share Statistics

Avg Vol (3 month) 3335.21k
Avg Vol (10 day) 3191.24k
Shares Outstanding 568.22M
Implied Shares Outstanding 668.22M
Float 831.89M
% Held by Insiders 11.16%
% Held by Institutions 188.56%
Shares Short (Apr 15, 2024) 43.39M
Short Ratio (Apr 15, 2024) 49.04
Short % of Float (Apr 15, 2024) 49.14%
Short % of Shares Outstanding (Apr 15, 2024) 44.97%
Shares Short (prior month Mar 15, 2024) 43.07M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-31.67%
Return on Equity (ttm)-58.74%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -122.54M
Net Income Avi to Common (ttm)-117.86M
Diluted EPS (ttm)-1.7500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)137.18M
Total Cash Per Share (mrq)2.01
Total Debt (mrq)35.66M
Total Debt/Equity (mrq)23.66%
Current Ratio (mrq)9.04
Book Value Per Share (mrq)2.22

Cash Flow Statement

Operating Cash Flow (ttm)-100.29M
Levered Free Cash Flow (ttm)-58.02M